http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101217713-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-07 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-14 |
filingDate | 2011-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2012-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2012-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101217713-B1 |
titleOfInvention | Fermentation Production Method of Throat Mushroom-Derived Thrombolytic Enzyme and Uses thereof |
abstract | The present invention is a fungus ( Auricularia) Auricula ) relates to a fermentation production method and its use of the thrombolytic enzyme derived from, specifically, the new thrombolytic enzyme derived from the mycelium mushroom mycelium has a different substrate specificity and a superior fibrin and fibrinogen degrading activity, It has a thrombolytic ability, blood aggregation inhibitory effect, antithrombotic effect, cerebral infarction effect and immune enhancing activity in and out of it, and thus can be usefully used for thrombolytic or blood circulation improving health food because it has no side effects. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111778351-A |
priorityDate | 2011-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 120.